HomeAI · summaries
Storia in 2 fonti
India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator says
Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites. This decisive action follows extensive inspections -- over 960 since late last year -- triggered by tragic child fatalities linked to these drugs. By December 31, manufacturers must adhere to World Health Organization standards.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator says
Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites. This decisive action follows extensive…
- ·
thehindubusinessline.com
India tightens drug quality norms, eyes biopharma push: Pharma Secretary
The Centre has begun cracking down on pharmaceutical manufacturers that fail to meet revised quality standards, with non-compliant companies being asked to shut down unless they…